KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹167 Cr | ₹130 Cr | ₹122 Cr | ₹104 Cr | ₹63 Cr |
What is the latest Total Expenditure of KILITCH DRUGS (INDIA) ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹167 Cr |
| Mar2024 | ₹130 Cr |
| Mar2023 | ₹122 Cr |
| Mar2022 | ₹104 Cr |
| Mar2021 | ₹63 Cr |
How is Total Expenditure of KILITCH DRUGS (INDIA) Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹167 Cr | 28.03 | |
| Mar2024 | ₹130 Cr | 6.76 | |
| Mar2023 | ₹122 Cr | 17.48 | |
| Mar2022 | ₹104 Cr | 64.11 | |
| Mar2021 | ₹63 Cr | - | |
Compare Total Expenditure of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹622.9 Cr | 9.9% | 2.3% | 20% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 9.9% |
2.3% |
20% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses